1. Signaling Pathways
  2. Metabolic Enzyme/Protease
  3. Phosphomannose Isomerase (PMI)

Phosphomannose Isomerase (PMI) (磷酸甘露糖异构酶 (PMI))

Phosphomannose Isomerase (PMI)

磷酸甘露糖异构酶 (PMI/MPI)、磷酸甘露糖变位酶 (PMM) 和 GDP-Man 焦磷酸化酶 (GMPP) 是参与 GDP-Man 生物合成的三种关键酶,而 GDP-Man 是细胞壁甘露聚糖生物合成和蛋白质糖基化所必需的。UDP-glucose (UDP-Glc)、UDP-GlcNAc 和 GDP-Man 是细胞壁生物合成所需的三种前体。PMI 催化果糖-6-磷酸 (Fru6P) 和甘露糖-6-磷酸 (Man6P) 之间的转化[1]。这种酶存在于哺乳动物、细菌和真菌中,在细胞壁合成、活力和细胞信号传导中起重要作用。PMI 缺乏与先天性糖基化障碍 (CDG) 有关。 PMI 抑制剂与甘露糖补充相结合可能有助于 N-糖基化正常化,并改善 CDG-Ia 病理情况[2]

Phosphomannose isomerase (PMI/MPI), phosphomannose mutase (PMM), and GDP-Man pyrophosphorylase (GMPP) are the three crucial enzymes involved in the biosynthesis of GDP-Man, which is required for cell wall mannan biosynthesis and protein glycosylation. UDP-glucose (UDP-Glc), UDP-GlcNAc, and GDP-Man are the three precursors required for cell wall biosynthesis. PMI catalyzes the conversion between fructose-6-phosphate (Fru6P) and mannose-6-phosphate (Man6P)[1]. This enzyme is present in mammals, bacteria, and fungi and plays an important role in cell wall synthesis, viability, and cell signaling. PMI deficiency is associated with congenital disorder of glycosylation. PMI inhibition combined with mannose supplementation might help normalize N-glycosylation and improve CDG-Ia pathology[2].

Phosphomannose Isomerase (PMI) 相关产品 (3):

Cat. No. Product Name Effect Purity Chemical Structure
  • HY-112945
    MLS0315771 Inhibitor 99.46%
    MLS0315771 是一种来源于有效的、磷酸甘露糖异构酶 (MPI) 的竞争性抑制剂, 其 IC50 值为~1 μM,Ki 值为 1.4 μM。
    MLS0315771
  • HY-138802
    ML089 Inhibitor 99.86%
    ML089 是一种口服有效的、选择性磷酸甘露糖异构酶 (PMI) 抑制剂,IC50 为 1.3 µM。ML089 可用于先天性糖基化障碍Ia的研究。
    ML089
  • HY-124890
    Thr101 Inhibitor 99.36%
    Thr101 是磷酸甘露糖异构酶 (PMI) 的抑制剂 (IC50=2.9 μM)。PMI 可与磷酸甘露糖变位酶 2 (PMM2) 竞争 Man-6-P 的结合位点,将 6- 磷酸甘露糖 (Man-6-P) 转化为 6-磷酸果糖 (Fru-6-P)。Thr101 只特异性抑制 PMI,不抑制 PMM2。Thr101 可用于糖基化 Ia 型先天性疾病 (CDG-Ia) 的研究。
    Thr101